Werewolf Therapeutics is paying millions to exit its Watertown headquarters early as the biotech searches for a buyer or ...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...
Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. The Dublin-based pharma is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results